Show simple item record

dc.contributor.authorLamarca, Angela
dc.contributor.authorGaldy, Salvatore
dc.contributor.authorBarriuso, Jorge
dc.contributor.authorMoghadam, Sharzad
dc.contributor.authorBeckett, Elizabeth
dc.contributor.authorRogan, Jane
dc.contributor.authorBacken, Alison C
dc.contributor.authorBillington, Catherine
dc.contributor.authorMcNamara, Mairéad G
dc.contributor.authorHubner, Richard A
dc.contributor.authorCramer, Angela
dc.contributor.authorValle, Juan W
dc.date.accessioned2018-11-13T17:13:28Z
dc.date.available2018-11-13T17:13:28Z
dc.date.issued2018
dc.identifier.citationThe HER3 pathway as a potential target for inhibition in patients with biliary tract cancers. 2018, 13 (10):e0206007 PLoS ONEen
dc.identifier.issn1932-6203
dc.identifier.pmid30335866
dc.identifier.doi10.1371/journal.pone.0206007
dc.identifier.urihttp://hdl.handle.net/10541/621341
dc.description.abstractExpression of human epidermal growth factor receptor (HER)2 and HER3 have been investigated in small BTC studies using variable scoring systems.
dc.language.isoenen
dc.rightsArchived with thanks to PloS oneen
dc.titleThe HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.en
dc.typeArticleen
dc.contributor.departmentDepartment of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdomen
dc.identifier.journalPLoS ONEen
html.description.abstractExpression of human epidermal growth factor receptor (HER)2 and HER3 have been investigated in small BTC studies using variable scoring systems.


Files in this item

Thumbnail
Name:
journal.pone.0206007 (1).pdf
Size:
2.013Mb
Format:
PDF
Description:
Full text open access article

This item appears in the following Collection(s)

Show simple item record